143 related articles for article (PubMed ID: 6565289)
21. Testing for new oral anticoagulants with LA-resistant Russells viper venom reagents. An in vitro study.
Exner T; Ellwood L; Rubie J; Barancewicz A
Thromb Haemost; 2013 Apr; 109(4):762-5. PubMed ID: 23364321
[No Abstract] [Full Text] [Related]
22. Oral anticoagulants and insecticides.
Fernández MA; Ballesteros S; Aznar J
Thromb Haemost; 1998 Oct; 80(4):724. PubMed ID: 9799010
[No Abstract] [Full Text] [Related]
23. Neutrophils release brakes of coagulation.
Ruf W; Ruggeri ZM
Nat Med; 2010 Aug; 16(8):851-2. PubMed ID: 20689544
[No Abstract] [Full Text] [Related]
24. Novel oral anticoagulants and diet: the potential for interaction.
Kamali F
Am J Hematol; 2009 Apr; 84(4):260-1. PubMed ID: 19253346
[No Abstract] [Full Text] [Related]
25. Editorial: Laboratory control of oral anticoagulants.
Lancet; 1975 Feb; 1(7902):317-8. PubMed ID: 46454
[No Abstract] [Full Text] [Related]
26. Is the bleeding time prolonged in oral anticoagulant treatment?
Rosendaal FR; Srámek R; Srámek A
Thromb Haemost; 1994 Jan; 71(1):157-8. PubMed ID: 8165639
[No Abstract] [Full Text] [Related]
27. New Reversal Agents for Oral Anticoagulants on the Horizon.
Mazur MD; Sivakumar W; Taussky P; Park MS
World Neurosurg; 2015 Dec; 84(6):1506-7. PubMed ID: 26481339
[No Abstract] [Full Text] [Related]
28. Laboratory measurement of the direct oral anticoagulants.
Dale BJ; Chan NC; Eikelboom JW
Br J Haematol; 2016 Feb; 172(3):315-36. PubMed ID: 26492202
[TBL] [Abstract][Full Text] [Related]
29. [Vitamin K antagonists].
Chabalier R; Lévy G
Ann Anesthesiol Fr; 1978; 19(10):IN-5N. PubMed ID: 35048
[No Abstract] [Full Text] [Related]
30. [Mechanism of action of vitamin K and how it is affected by anticoagulants].
Schade R; Janowski K
Pharmazie; 1976; 31(9):585-9. PubMed ID: 798207
[No Abstract] [Full Text] [Related]
31. New Oral Anticoagulants: Need and Challenges in a Developing Country.
Khan M; Wasay M
J Coll Physicians Surg Pak; 2016 Jul; 26(7):551-2. PubMed ID: 27504541
[No Abstract] [Full Text] [Related]
32. Letter: Coagulopathy and fat-soluble vitamins.
Schrogie JJ
JAMA; 1975 Apr; 232(1):19. PubMed ID: 1172961
[No Abstract] [Full Text] [Related]
33. Letter: Influence of secondary medication on the action of anticoagulants.
Med Klin; 1973 Dec; 68(50):1668. PubMed ID: 4782874
[No Abstract] [Full Text] [Related]
34. [Unfavorable and problematic drug combinations. II].
Glogner P
Internist (Berl); 1970 Jul; 11(7):260-1. PubMed ID: 4939615
[No Abstract] [Full Text] [Related]
35. Vitamin K and the oral anticoagulant drugs.
O'Reilly RA
Annu Rev Med; 1976; 27():245-61. PubMed ID: 779597
[TBL] [Abstract][Full Text] [Related]
36. [Adverse reactions of coumarin derivative interactions].
Wiela-Hojeńska A; Orzechowska-Juzwenko K
Pol Merkur Lekarski; 2000 Sep; 9(51):600-1. PubMed ID: 11126983
[TBL] [Abstract][Full Text] [Related]
37. Targeted inhibition of coagulation: oral agents show promise in phase III trials.
Bauer KA
J Thromb Haemost; 2007 Nov; 5(11):2175-7. PubMed ID: 17764539
[No Abstract] [Full Text] [Related]
38. Practical recommendations on incorporating new oral anticoagulants into routine practice.
Randhawa J; Thiruchelvam N; Ghobrial M; Spiro T; Clark B; Haddad A; Daw H
Clin Adv Hematol Oncol; 2014 Oct; 12(10):675-83. PubMed ID: 25658892
[TBL] [Abstract][Full Text] [Related]
39. Oral anticoagulants--the totem and the taboo.
Breckenridge A
Br Med J; 1976 Feb; 1(6007):419-23. PubMed ID: 766893
[No Abstract] [Full Text] [Related]
40. Direct Oral Anticoagulant Agents: Pharmacologic Profile, Indications, Coagulation Monitoring, and Reversal Agents.
Rose DK; Bar B
J Stroke Cerebrovasc Dis; 2018 Aug; 27(8):2049-2058. PubMed ID: 29753603
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
